QTRX
$4.72
Quanterix Corporation, a life sciences company in North America, Europe, the Middle East, Africa, and the Asia Pacific regions.
Historical Price
Peer Comparison
Whystock Valuation Model
Fundamentals
Quanterix Corporation, a life sciences company in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Si...
Recent News
Quanterix (QTRX) Q4 2025 Earnings Call Transcript
Need a quote from a Motley Fool analyst? With me on today's call are Everett Cunningham, Quanterix Corporation President and CEO, and Vandana Sriram, Quanterix Corporation Chief Financial Officer. During the course of today's presentation, we will make forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act.
Quanterix Corporation Q4 2025 Earnings Call Summary
Moby summary of Quanterix Corporation's Q4 2025 earnings call
Quanterix Corp (QTRX) Q4 2025 Earnings Call Highlights: Revenue Surge Amidst Strategic Shifts
Quanterix Corp (QTRX) reports a 25% revenue increase, strategic innovations, and a path to cash flow breakeven by late 2026.
Quanterix Q4 Earnings Call Highlights
Quanterix (NASDAQ:QTRX) reported fourth-quarter 2025 revenue of $43.9 million, up 25% from the prior year and up 7% sequentially, as the company cited a stronger-than-expected quarter driven in part by “pent-up demand” from academic customers. On the company’s earnings call, newly appointed Presiden
Quanterix Corporation (QTRX) Reports Q4 Loss, Beats Revenue Estimates
Quanterix (QTRX) delivered earnings and revenue surprises of -40.74% and +14.71%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?